PanAgora Asset Management »

C4 Therapeutics shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $228k 87k 2.63
2023-03-31 $339k 108k 3.14

More positions owned by PanAgora Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Philip Morris International (PM)
Wal-Mart Stores (WMT)
Ge Aerospace Com New (GE)

View all positions for PanAgora Asset Management

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
Two Sigma Investments
Daniel D. Thurber
Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics